The Josep Carreras Leukaemia Research Institute (IJC) is a comprehensive cancer research center dedicated to conduct research and drive innovation in the epidemiological, preventive, clinical, translational, and basic aspects of leukaemia and other hematologic malignancies, with the final aim of finding a cure for these diseases. It was created in 2010, and since then has experienced an exponential growth.
The IJC is also part of the network of Excellence Research Centers of Catalonia (CERCA) and was accredited as a Severo Ochoa Center of Excellence by the Ministry of Science, Innovation, and Universities in 2024. Since 2018, the Institute has also been accredited by the Scientific Foundation of the Spanish Association Against Cancer (FCAECC) Additionally, IJC is one of the centers integrated into the Institut de Recerca Germans Trias i Pujol (IGTP) accreditation as Accredited Health Research Institute (IIS) by the Carlos III Health Institute (ISCIII).
The IJC's main headquarters is located within the Can Ruti Biomedical Campus, alongside other leading biomedical institutions, providing direct access to cutting-edge scientific and technological facilities, as well as complementary community services. The IJC has six locations integrated into reference hospitals: Hospital Germans Trias i Pujol, Hospital Clínic, Hospital Sant Pau, Hospital Josep Trueta, Hospital del Mar and Hospital San Joan de Déu. This facilitates close collaboration between basic and clinical researchers, fostering translational research that integrates basic science with clinical practice in clinical settings.
We are looking for a motivated Laboratory Technician for the Endothelial pathobiology and microenvironment group, led by Dr. Mariona Graupera. This contract is Funded by Blood Cancer United SCOR grant 7027-23 (Title: Targeting Unmet Needs For B-cell Lymphomas).
RESEARCH DESCRIPTION
Our research is devoted to studying the biology of the endothelium and its role in disease, with the aim of developing therapeutic strategies to target this compartment. Specifically, we aim to uncover fundamental insights into vessel growth and function in a developmental setting, as well as identify pathological contexts in which the vasculature plays a critical role in cancer, such as Lymphoma.
MAIN RESPONSABILITIES
- Manage a complex mouse colony
- Wean and genotype mice
- Process tissue, including cutting and staining
- Provide support to specific lab techniques
- Isolate primary cells
- Oversee the organization of the lab
WHAT WE NEED
- Degree or technical qualification in Biology, Biotechnology, Biomedicine, or a related field.
- License to work with mice
- Experience working with mice.
- Experience in administering substances via different routes will be considered an asset, including intraperitoneal, intravenous, subcutaneous, intratibial, intrahepatic, and oral gavage.
- Fluency in English will be considered a plus.
- Willingness to learn and strong teamwork skills
- Pro-active, responsible and well-organised
- Good interpersonal skills and the ability to work with other team members
WHAT WE OFFER
- Temporary contract (Indefinido por actividades científico-técnicas) Funded by Blood Cancer United SCOR grant 7027-23 (Title: Targeting Unmet Needs For B-cell Lymphomas).
- Full time contract of 39 hours per week.
- Highly competitive salary
- Flexible remuneration program (kindergarten and other measures).
- An exciting and innovative research project.
- Be part of a young, collaborative and international work environment with cutting-edge technologies and interdisciplinary teams of scientists, including experts in medicine, immunology, genomics and bioinformatics.
- Incorporation in a multinational and highly collaborative team.
- The stimulating environment of the Barcelona metropolitan area.
DEADLINE
Please submit your application by 20 July 2026.
WHO WE ARE?
The mission of the Josep Carreras Leukaemia Research Institute is to conduct research and drive innovation in the epidemiological, preventive, clinical, translational, and basic aspects of cancer, with a special emphasis on Leukaemia and other malignant blood diseases, with the aim of finding a cure for these diseases.
The IJC’s vision is to be a world-class reference and excellent research center that contributes to the improvement of results, and the cure of patients affected by leukaemia and other malignant haemopathies, through innovation, sustainability, social responsibility, talent, and professional experience.
In 2019, IJC was honored with the “Human Resources Excellence in Research Award” by the European Commission, recognizing the alignment of our human resources policies with the European Charter for Researchers and Code of Conduct for the Recruitment of Researchers. The Human Resources Strategy for Researchers (HRS4R) guides research centers of excellence in implementing and upholding these standards within their policies, emphasizing training, professional development, and mobility opportunities.
The IJC’s commitment to these values and principles strengthens our internal policies and ensures that our members have the optimal conditions and environment for their professional development.
The Board of Trustees is composed of representatives of the Generalitat de Catalunya (regional government), University of Barcelona, Autonomous University of Barcelona, the City of Badalona and the Jose Carreras International Leukaemia Foundation
The Catalan government provides hard money on an annual basis. The Jose Carreras International Leukaemia Foundation provides start-up funds, project funds as well as financial support for investments.
The JCI has an international scientific advisory board served by prominent researchers from US and Europe.
The IJC has been awarded ERC and other EU grants.
The IJC is an equal-opportunity employer. We evaluate qualified applicants without regard to race, color, religion, sex, national origin, disability, or other legally protected characteristics.
